Physician-led access
Investigators are selected for therapeutic experience, patient population, and protocol fit.
For sponsors & CROs
A site network built for consistent protocol execution.
Access 40+ research sites through one contract and one budget, supported by centralized startup, protocol intelligence, and protocol-permitted home visits.
40+
Research Sites
Community and specialty research sites nationwide
140
Phase I Beds
Across two dedicated early-phase units
Why Core
Protocol-matched investigators. One agreement. Clear performance visibility.
Centralized startup
Activate participating sites through one agreement and coordinated startup process.
Performance visibility
Review activation, enrollment, and retention performance across participating sites.
Capabilities
Coordinated site execution through one operating structure
Site selection
Feasibility screens investigators and sites against the protocol’s therapeutic, patient-population, and capacity requirements; recruitment is planned through each site’s existing patient relationships.
Startup & activation
Contracting, budgets, and regulatory submissions are coordinated centrally under one agreement and one budget, with activation status reported for each participating site.
TrialPulse® protocol intelligence
TrialPulse turns the protocol and each amendment into version-controlled, cited guidance, so study teams across participating sites work from the current approved version. Learn about TrialPulse
OnSite Nurses® home & hybrid execution
OnSite Nurses extends protocol-permitted visits into participants’ homes, workplaces, or care facilities, with scope, training, and delegation agreed for each study before activation. Explore home-enabled execution
Long-term follow-up
ReEngage Research® supports missed-visit recovery and long-term follow-up through site-authorized participant outreach, centralized case tracking, and coordination of protocol-permitted next steps. Learn about ReEngage Research
Phase I units
Two dedicated early-phase units with 140 beds, activated and reported through the same centralized startup as the rest of the network. Explore Phase I capacity
Therapeutic areas
Depth where you need it
Investigator depth across priority therapeutic areas — each an entry point for a feasibility conversation.
Metabolic & Cardiovascular
Oncology
CNS & Pain
Immunology & Specialty Medicine
Infectious Disease & Vaccines
Pulmonology
Gastroenterology
Nephrology
Clinical Operations
Bring us your next study.
Share the synopsis or protocol and Core will identify the investigators, sites, and execution model best aligned with the study.
